Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

43.65
Delayed Data
As of Jul 29
 +0.04 / +0.09%
Today’s Change
40.67
Today|||52-Week Range
68.00
-5.70%
Year-to-Date
New Strong Sell Stocks for July 28th
Jul 28 / Zacks.com - Paid Partner Content
Dr. Reddy's Laboratories Ltd (ADR) Is Tanking Today -- Here's Why
Jul 26 / MotleyFool.com - Paid Partner Content
Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y
Jul 27 / Zacks.com - Paid Partner Content
Dr Reddy's Laboratories (RDY) Highlighted As Weak On High Volume
Jul 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close43.61
Today’s open43.55
Day’s range43.41 - 43.85
Volume293,680
Average volume (3 months)394,371
Market cap$7.4B
Dividend yield0.72%
Data as of 4:02pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.58%
Revenue growth (last year)-2.51%
P/E ratio0.4
Price/Sales3.28
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc0.000.00%
ALKSAlkermes Plc+1.77+3.68%
VRXValeant Pharmaceutic...-0.83-3.59%
SGENSeattle Genetics Inc+0.69+1.46%
Data as of 4:08pm ET, 07/29/2016

Financials

Last reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts

Partner Offers

Search for Jobs